Cladosporium sphaerospermum
Star0
Identification
- Summary
Cladosporium sphaerospermum is an extract from Cladosporium sphaerospermum used in allergy testing.
- Generic Name
- Cladosporium sphaerospermum
- DrugBank Accession Number
- DB10432
- Background
Cladosporium sphaerospermum is a fungus which can provoke allergic reactions. Cladosporium sphaerospermum extract is used in allergenic testing.
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
- Allergenics
Allergen Extract - Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Avoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Cladosporium Sphaerospermum Injection, solution 20000 [PNU]/1mL Subcutaneous ALK-Abello, Inc. 1965-01-01 2023-05-18 US Cladosporium sphaerospermum Solution 0.05 g/1mL Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US Cladosporium Sphaerospermum Injection, solution 0.001 g/1mL Subcutaneous ALK-Abello, Inc. 1965-01-01 2023-05-18 US Cladosporium Sphaerospermum Injection, solution 1000 [PNU]/1mL Intradermal ALK-Abello, Inc. 1965-01-01 2023-05-22 US Cladosporium Sphaerospermum Injection, solution 10 [PNU]/1mL Subcutaneous ALK-Abello, Inc. 1965-01-01 2021-11-30 US Cladosporium Sphaerospermum Injection, solution 20000 [PNU]/1mL Subcutaneous ALK-Abello, Inc. 1965-01-01 2023-05-18 US Cladosporium Sphaerospermum Injection, solution 10000 [PNU]/1mL Subcutaneous ALK-Abello, Inc. 1965-01-01 2023-05-18 US Cladosporium sphaerospermum Solution 0.1 g/1mL Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US Cladosporium Sphaerospermum Injection, solution 0.10 g/1mL Percutaneous ALK-Abello, Inc. 1965-01-01 2023-05-22 US Cladosporium Sphaerospermum Injection, solution 1000 [PNU]/1mL Subcutaneous ALK-Abello, Inc. 1965-01-01 2023-05-18 US - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image AHH Mold Mix Cladosporium sphaerospermum (13333.333 [PNU]/1mL) + Alternaria alternata (13333.333 [PNU]/1mL) + Cochliobolus sativus (13333.333 [PNU]/1mL) Solution Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US AHH Mold Mix Cladosporium sphaerospermum (0.0166 g/1mL) + Alternaria alternata (0.0166 g/1mL) + Cochliobolus sativus (0.0166 g/1mL) Solution Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US AHH Mold Mix Cladosporium sphaerospermum (0.00033 g/1mL) + Alternaria alternata (0.00033 g/1mL) + Cochliobolus sativus (0.00033 g/1mL) Solution Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US AHH Mold Mix Cladosporium sphaerospermum (0.0166 g/1mL) + Alternaria alternata (0.0166 g/1mL) + Cochliobolus sativus (0.0166 g/1mL) Solution Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US Mixed Molds Cladosporium sphaerospermum (20000 [PNU]/1mL) + Alternaria alternata (20000 [PNU]/1mL) + Aspergillus niger var. niger (20000 [PNU]/1mL) + Aspergillus oryzae (20000 [PNU]/1mL) + Aspergillus repens (20000 [PNU]/1mL) + Aspergillus terreus (20000 [PNU]/1mL) + Penicillium chrysogenum var. chrysogenum (20000 [PNU]/1mL) Injection, solution Subcutaneous ALK-Abello, Inc. 1998-02-23 2021-11-30 US Mixed Molds Cladosporium sphaerospermum (40000 [PNU]/1mL) + Alternaria alternata (40000 [PNU]/1mL) + Aspergillus niger var. niger (40000 [PNU]/1mL) + Aspergillus oryzae (40000 [PNU]/1mL) + Aspergillus repens (40000 [PNU]/1mL) + Aspergillus terreus (40000 [PNU]/1mL) + Penicillium chrysogenum var. chrysogenum (40000 [PNU]/1mL) Injection, solution Subcutaneous ALK-Abello, Inc. 1965-01-01 2023-05-24 US Mixed Molds Cladosporium sphaerospermum (10000 [PNU]/1mL) + Alternaria alternata (10000 [PNU]/1mL) + Aspergillus niger var. niger (10000 [PNU]/1mL) + Aspergillus oryzae (10000 [PNU]/1mL) + Aspergillus repens (10000 [PNU]/1mL) + Aspergillus terreus (10000 [PNU]/1mL) + Penicillium chrysogenum var. chrysogenum (10000 [PNU]/1mL) Injection, solution Subcutaneous ALK-Abello, Inc. 1998-02-23 2023-05-24 US Mixed Molds Cladosporium sphaerospermum (20000 [PNU]/1mL) + Alternaria alternata (20000 [PNU]/1mL) + Aspergillus niger var. niger (20000 [PNU]/1mL) + Aspergillus oryzae (20000 [PNU]/1mL) + Aspergillus repens (20000 [PNU]/1mL) + Aspergillus terreus (20000 [PNU]/1mL) + Penicillium chrysogenum var. chrysogenum (20000 [PNU]/1mL) Injection, solution Subcutaneous ALK-Abello, Inc. 1965-01-01 2023-05-24 US Mixed Molds Cladosporium sphaerospermum (10000 [PNU]/1mL) + Alternaria alternata (10000 [PNU]/1mL) + Aspergillus niger var. niger (10000 [PNU]/1mL) + Aspergillus oryzae (10000 [PNU]/1mL) + Aspergillus repens (10000 [PNU]/1mL) + Aspergillus terreus (10000 [PNU]/1mL) + Penicillium chrysogenum var. chrysogenum (10000 [PNU]/1mL) Injection, solution Subcutaneous ALK-Abello, Inc. 1965-01-01 2023-05-24 US Mixed Molds Cladosporium sphaerospermum (0.1 g/1mL) + Alternaria alternata (0.1 g/1mL) + Aspergillus niger var. niger (0.1 g/1mL) + Aspergillus oryzae (0.1 g/1mL) + Aspergillus repens (0.1 g/1mL) + Aspergillus terreus (0.1 g/1mL) + Penicillium chrysogenum var. chrysogenum (0.2 g/1mL) Injection, solution Percutaneous ALK-Abello, Inc. 1998-02-23 2023-05-24 US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- P87YCA1U8R
- CAS number
- Not Available
References
- General References
- Not Available
- External Links
- PubChem Substance
- 347910601
- 867202
- Wikipedia
- Cladosporium_sphaerospermum
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Solution Intradermal; Percutaneous; Subcutaneous 100 mg/1ml Injection, solution Intradermal 1000 [PNU]/1mL Injection, solution Percutaneous 0.10 g/1mL Injection, solution Subcutaneous 0.001 g/1mL Injection, solution Subcutaneous 10 [PNU]/1mL Injection, solution Subcutaneous 100 [PNU]/1mL Injection, solution Subcutaneous 1000 [PNU]/1mL Injection, solution Subcutaneous 10000 [PNU]/1mL Injection, solution Subcutaneous 20000 [PNU]/1mL Injection, solution Subcutaneous 40000 [PNU]/1mL Solution Intradermal; Percutaneous; Subcutaneous 0.001 g/1mL Solution Intradermal; Percutaneous; Subcutaneous 0.05 g/1mL Solution Intradermal; Percutaneous; Subcutaneous 0.1 g/1mL Injection, solution Percutaneous Injection, solution Subcutaneous Solution Intradermal; Percutaneous; Subcutaneous - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at December 01, 2015 20:03 / Updated at June 12, 2020 16:53